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ABSTRACT
Organoid cultures in 3D matrices are relevant mod-
els to mimic the complex in vivo environment that
supports cell physiological and pathological behav-
iors. For instance, 3D epithelial organoids recapitu-
late numerous features of glandular tissues includ-
ing the development of fully differentiated acini that
maintain apico-basal polarity with hollow lumen. Ef-
fective genetic engineering in organoids would bring
new insights in organogenesis and carcinogenesis.
However, direct 3D transfection on already formed
organoids remains challenging. One limitation is
that organoids are embedded in extracellular ma-
trix and grow into compact structures that hinder
transfection using traditional techniques. To address
this issue, we developed an innovative approach for
transgene expression in 3D organoids by combin-
ing single-cell encapsulation in Matrigel microbeads
using a microfluidic device and electroporation. We
demonstrate that direct electroporation of encapsu-
lated organoids reaches up to 80% of transfection
efficiency. Using this technique and a morphologi-
cal read-out that recapitulate the different stages of
tumor development, we further validate the role of
p63 and PTEN as key genes in acinar development
in breast and prostate tissues. We believe that the
combination of controlled organoid generation and
efficient 3D transfection developed here opens new
perspectives for flow-based high-throughput genetic
screening and functional genomic applications.
INTRODUCTION
Tissues and organs are multicellular structures that self-
organize in three dimensions (3D). Cells within a tissue
interact with neighboring cells and with extracellular ma-
trix (ECM) through biochemical and mechanical cues that
maintain speciicity and homeostasis of biological tissues.
While traditional 2D cultures on rigid surfaces fail to re-
produce in vivo cell behavior, 3D matrices are becoming in-
creasingly popular supports for cell cultures because they
allow mimicking the complex environment that supports
cell physiological functions (1) to better predict in vivo re-
sponses (2,3) and thus to limit the need for animal models
(4). For example, epithelial organoid culture in Matrigel re-
capitulates numerous features of glandular tissues includ-
ing the development of fully differentiated acini that main-
tain apico-basal polarity by enclosing a central lumen (5).
Therefore, deciphering the key genetic networks underlying
epithelial differentiation and polarity in organoids brings
new insights in organogenesis and allows us to better un-
derstand how they may be disrupted in disease states such
as cancer. RNA interference (RNAi) and plasmid transfec-
tion have been widely used as powerful tools to alter the
expression of speciic genes and to observe resulting pheno-
typic changes (6). While nucleic acid transfection is highly
effective in the majority of mammalian cells cultured un-
der standard 2D conditions, additional obstacles are en-
countered for transfection of solid tissues or 3D models.
Indeed, one limitation is that organoids are embedded in
ECM, which constitutes a barrier for eficient transfection.
Moreover, organoids grow into dense and compact struc-
tures that impede diffusion, penetration and cellular accu-
mulation of genetic material, which makes transfection via
traditional techniques dificult (7–9). In addition, quiescent
cells that are located at the center of 3D structures are often
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refractory to transfection (10). Thus, direct 3D transfection
on already formed organoids remains challenging.
Gene delivery methods are usually divided between vi-
ral and non-viral vectors. Viral vectors provide the highest
transfection eficiency but have serious limitations such as
the size of DNA carried in the vector, intrinsic biosafety
issues, concern for viral insertion mutagenesis (11) and an
inability to diffuse through ECM (12). To overcome these
limitations, a common strategy is to dissociate organoids
into single cells or small group of cells before transfect-
ing them and subsequently re-embedding them into Ma-
trigel (13–15). Hence, viral transduction is limited to multi-
cellular tumor spheroids (MCTS) or dissociated organoids
devoid of ECM with heterogeneous eficiency and the need
to further select transduced structures (16). However, under
these conditions, the natural self-organization of organoids
is lost along with their spatial architecture and polarity, ul-
timately going back to a 2D cell transfection. Among non-
viral-based approaches, lipofection and electroporation are
widely used in biological research and usually allow more
than 80% of transfection eficiency in 2D cultures. How-
ever, they have been proven to be relatively ineficient in
transfecting 3D cultures with transfection eficiencies lower
than 5 and 20%, respectively (7–9). A common strategy to
circumvent this issue is to transfect cells that are grown
in 2D and to transfer them into 3D culture, which limits
the biological issues that we can address (15,17). However,
progeny cells that colonize the matrix will not be trans-
fected and will gradually lose the desired effect. In addi-
tion, this method becomes highly challenging when per-
forming high-throughput assays because it requires sequen-
tially transfecting cells, detaching them and seeding them
onto ECM. Gene-activated matrices that combine scaffolds
or hydrogels and lipid-based gene delivery reagents were de-
veloped to allow direct in situ transfection of cells that grow
in 3D matrices (18,19). While this system maintains a per-
manent transfection with 60–90% of siRNA-mediated gene
knock-down during 3D organoid development, it does not
allow transfection at different time points. To identify ef-
icient non-viral gene delivery methods that are compati-
ble with high-throughput analysis of 3D models in vitro,
we systematically evaluate the methods for siRNA trans-
fer into 3D organoids cultured withinMatrigel microbeads,
which are produced via low-focusing-based microluidics
(20). Droplet or digital microluidic aims at forming water-
in-oil or oil-in-water emulsions by using microfabricated
chips. It ensures high-throughput formation of droplets of
controlled size, shape and monodispersity. In this study, we
adapted this method to produce Matrigel-in-oil emulsion,
leading to a high-throughput production of Matrigel mi-
crobeads were each single microbead can be considered as
a single ‘bioreactor’ for 3D epithelial cell culture. Here, we
took advantage of the reduced amount of ECM that sur-
rounds organoids and the ease of microbead manipulation
to develop a method for ex vivo gene function studies. In
particular, we demonstrate the eficiency of gene delivery us-
ing electroporation in combination with microencapsulated
3D organoids.
MATERIALS AND METHODS
Cell lines and 2D cell culture
The RWPE-1 cell line was obtained from ATCC (CRL-
11609). This cell line was derived from non-neoplastic hu-
man prostate epithelial cells via immortalization with hu-
man papillomavirus. RWPE-1 cells were previously used
as a model for normal prostate epithelial cell behavior,
as characterized by a polarized acinar morphology in 3D
cultures (20). RWPE-1 cells were maintained in KSFM
(Gibco Life Technologies, Courtaboeuf, France) supple-
mented with 5 ng/ml Epidermal Growth Factor (Gibco), 50
g/ml Bovine Pituitary Extract (Gibco) and 1% Penicillin-
Streptomycin (Gibco). Cells were cultured up to 70% con-
luence and seeded in T25 Flasks at a density of 2 × 104
viable cells/cm2.The MCF10A cell line was obtained from
ATCC (CRL-10317). This cell line was derived from spon-
taneously immortalized non-neoplastic human breast ep-
ithelial cells.MCF10A cells were used as amodel for normal
breast epithelial cell behavior as characterized by a polar-
ized acinar morphology in 3D cultures. MCF10A cells were
maintained in DMEM/F12 (Gibco) supplemented with
5% Horse serum (Eurobio, AbCys, Courtaboeuf, France),
20 ng/ml Epidermal Growth Factor (Life Technologies),
10 g/ml Insulin (Sigma-Aldrich, St Quentin Fallavier,
France), 0.5 g/ml Hydrocortisone (Sigma-Aldrich), 100
ng/ml Cholera toxin (Sigma-Aldrich) and 1% Penicillin-
Streptomycin (Gibco). Cells were maintained in culture un-
til ∼80% conluence and seeded in T25 Flasks at a den-
sity of 3 × 104 viable cells/cm2. RWPE-1 and MCF10A
cells that stably express GFP (RWPE-1-GFP (engineered in
our lab) andMCF10A-GFP, (kind gifts of Dr Odile Filhol-
Cochet, CEA Grenoble)) were obtained via transduction
using a lentiviral vector that encodes the enhanced green
luorescent protein cDNA (GFP). GFP+ cells were sorted
using a MoFlo cell sorter (Beckman Coulter, Villepinte,
France). Cell number and viability were measured via try-
pan blue dye exclusion staining using an EVE™ Automatic
Cell Counter (NanoEnTek, VWR, Strasbourg, France).
Matrigel microbead production
A Cyclic Olein Copolymer microluidic chip with a low
focusing geometry connected to a FlowPad microluidic
platform was used within a compact bench-top cooler sys-
tem (Figure 1A). Two different microluidic chips were de-
signed, with channel square cross-sections of 200× 200 and
300 × 300 m to produce microbeads 250 and 450 m in
diameter, respectively. Perluorinated oil HFE-7500 (3M,
Cergy-Pontoise, France) was used with a 1.5% w/v PFPE-
PEG-PFPE surfactant (Chemipan R&D laboratories, War-
saw, Poland) as a continuous phase and Matrigel (Corn-
ing, Brumath, France) premixed with cells as a dispersed
phase. All experiments were performed at 4◦C to prevent
Matrigel polymerization inside microluidic channels. Cells
were mixed with Matrigel and injected in a reservoir in a
Fluiwell-4C device (Fluigent, Villejuif, France). The low
inside the microluidic device was induced and controlled
using a microluidic low control system (Fluigent). A pres-
sure of 40 mbar was applied to the cell/Matrigel mix as
well as to the oil/surfactant mix. The cell/Matrigel mix was
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Figure 1. High-throughput Matrigel microbead production for 3D organoid culture. (A) Scheme of the microluidic platform that was used for Matrigel
microbead production. The cell/Matrigel mix was pushed into the low-focusing junction and cut via perluorinated oil low, which led to the formation of
Matrigel droplets. Flow inside the microluidic device was induced by a Fuigent low control system. Then, droplets were allowed to polymerize at 37◦C for
20 min. Real-time Matrigel droplet formation in perluorinated oil was controlled using an acA800–560 m camera. (B) (a) Single cells dispersed within a
gel generate acini that are overlapping and heterogeneous in size and shape (left panel), which is in contrast to single cells microencapsulated within a gel
(right panel). (b) Table that recapitulates the beneits of the 3D culture setup in microbeads over traditional 2D and 3D culture.
pushed into the low-focusing junction and cut by perlu-
orinated oil low, which led to the formation of Matrigel
droplets. Matrigel droplets were collected in an Eppendorf
tube for ∼15 min and subsequently incubated at 37◦C for
20 min to promote Matrigel droplet polymerization into
microbeads. Transfer of microbeads from oil into culture
media was achieved by mixing microbeads, culture media
and 1H, 1H, 2H, 2H-Perluoro-1-octanol (Sigma-Aldrich).
Real-time Matrigel droplet formation in perluorinated oil
was controlled using a camera (Basler, i2c, Pessac, France,
acA800–510 m). Microbeads were imaged after the trans-
fer from oil into culture media with an inverted microscope
(Olympus KX41, Rungis, France).
3D culture in Matrigel microbeads
For the acinar morphogenesis assay, RWPE-1 cells in
Matrigel microbeads were cultured in KSFM supple-
mented with 50 ng/ml epidermal growth factor, 2% fe-
tal bovine serum (PAA Clone, Les Mureaux, France),
1% Matrigel and 1% Penicillin-Streptomycin in multiwell
plates. MCF10A cells inMatrigel microbeads were cultured
in DMEM/F12 supplemented with 5% Horse serum, 20
ng/ml Epidermal Growth Factor, 10g/ml Insulin (Sigma-
Aldrich), 0.5 g/ml Hydrocortisone (Sigma-Aldrich), 100
ng/ml Cholera toxin (Sigma-Aldrich), 2% Matrigel and
1% Penicillin-Streptomycin in multiwell plates. Cell cul-
ture medium was changed every two days. All cells were
routinely cultured in a humidiied atmosphere with 5%
CO2 at 37
◦C. For long-term organoid storage, Matrigel mi-
crobeads containing organoids at different developmental
stages were frozen using 10% cryoprotective dimethylsul-
foxide (DMSO, Sigma-Aldrich) in media according to stan-
dard procedures (21).
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RNAi and plasmid transfection
To assess the transfection eficiency, RWPE-1-GFP and
MCF10A-GFP cells, which were seeded in Matrigel mi-
crobeads, were allowed to develop into organoids for 4
and 11 days, respectively, andwere subsequently transfected
with siRNA (siAllStars, siAllStars AF546, siGFP, Qiagen,
Les Ulis, France) or plasmid (pMAX-GFP, Lonza, Bazel,
Switzerland) at a inal concentration of 20 nM. This se-
lected dose is used in routine in our lab (22) and is con-
sistent with other works from the literature working with
MCF10A (23) or RWPE1 (24). As a negative control, a
siRNA without homology to any known mammalian gene
was used (AllStars negative control, Qiagen, Valencia, CA,
USA). AF546 stands for siRNA AllStars labeled at the 3′
end of the sense strand with an Alexa Fluor 546 nm lu-
orescent dye. For each experiment, cell viability was mea-
sured in controls (untreated cells, cells treated with siRNA
alone, cells transfected without siRNA and cells trans-
fected with siRNA AllStars) as well as in cells transfected
with the different siRNA used. No signiicant differences
should be observed between the different conditions of
paired experiments to ensure a robust data analysis (see
section “direct transfection of organoids in Matrigel mi-
crobeads”). Different transfection reagents were tested in-
cluding Lipofectamine RNAiMax (Invitrogen, Life Tech-
nologies), Oligofectamine (Invitrogen), 3DFect, 3DFectIN
(OZBiosciences,Marseille, France) or TransIT2020 (Mirus,
Euromedex, Mundolsheim, France) according to the man-
ufacturer’s instructions. Electroporation was assessed us-
ing an AMAXA Transfection System (Lonza, program
X-001) by resuspending microbeads in an electropora-
tion buffer (HEPES 21 mM, NaCl 137 mM, KCl 5 mM,
Na2HPO4–7H2O 0.7 mM, Dextrose 6 mM, pH 7.15). GFP
was used as a surrogate RNAi target in determining siRNA
knock-down eficiency with the variety of methods. After
3 days, the cells were extracted from microbeads, and GFP
intensity was analyzed using low cytometry. Mean luores-
cence intensities (MFI) were used to quantify siRNA ex-
tinction eficiency as follows: extinction eficiency = 100 −
(MFI siGFP/MFI siAllStars) × 100. For the functional
transfection assays, RWPE-1 and MCF10A organoids in
Matrigel microbeads were transfected at different time
points with siRNA targeting p63 (sip63, Qiagen) or PTEN
(siPTEN, Qiagen) genes and siRNA AllStars (Qiagen) at a
inal concentration of 20 nM.
Lentiviral transduction
RWPE-1 cells in Matrigel microbeads were allowed to de-
velop into organoids for 4 days in media without an-
tibiotics. After addition of 8 g/ml Polybrene (Sigma-
Aldrich), organoids were infected with lentiviruses diluted
in assay media for 24 h. Then, half of the media was re-
placed with freshmedia. After 2 days, 0.2g/ml Puromycin
(Sigma-Aldrich) was added to select transduced cells. Af-
ter 3 days of Puromycin selection, cells were extracted
from organoids and analyzed via low cytometry. Lentivi-
ral transduction was performed using a Multiplicity of In-
fection (MOI) ranging from 0 to 20. MOI was derived as
the number of virus particles against the average number of
cells per mature organoid.
Flow cytometry
After transfection, microbeads were dispatched in 48-well
plates or 24-well-plates. Superposing microbeads should be
avoided as it could induce microbead aggregation during
long-term culture experiments and be critical in transfec-
tion experiments. Adding Matrigel in 3D culture medium
(see section “3D culture in Matrigel microbeads”) is essen-
tial to prevent cells from escaping microbeads and grow-
ing in 2D at the bottom of the plates. Single cells were ex-
tracted fromMatrigel microbeads by combining prolonged
trypsin incubation and several vortex steps (Supplemen-
tary Figure S1).Matrigel microbeads were pelleted by quick
centrifugation (30 s), and rinsed twice with phosphate-
buffered saline (PBS) 1× before addition of 500 l of
Trypsin-ethylenediaminetetraacetic acid 1× 0.05% (Gibco,
Ref 25300–054). Samples were incubated for 30 min at 37◦C
and vortexed for about 20 s every 5min. Cells were then pel-
leted by centrifugation (5 min at 150 G) and rinsed twice in
PBS 1× before low cytometry analysis. In all experiments,
gate was performed on 10 000 viable cells per condition.
Cells were analyzed via low cytometry using an LSR II low
cytometer (Becton Dickinson) gated on 10 000 viable cells
per condition.
Apoptosis assay
CellEvent (Invitrogen) staining was performed to detect ac-
tivated Caspase-3/7 and to quantify apoptosis in organoids
within Matrigel microbeads. Briely, Matrigel microbeads
were incubated 30 min at 37◦C with 10 M of Cell Event
reagent. As a positive cell death control, Matrigel mi-
crobeads were transfected with siRNACell Death (AllStars
Hs Cell Death siRNA from Qiagen, 20 nM). After Cell
Event staining, Hoechst staining was performed and images
were acquired using a High Content CellInsight Screen-
ing Platform (ThermoFischer Scientiic) for all conditions.
Analysis was performed using R software and the percent-
age of dead organoids was evaluated based on negative con-
trol levels (Supplementary Figure S2).
Morphological analysis
Morphological analysis of 3D structures was performed by
eye counting under a phase microscope. While this method
might appear long and laborious, it requires less time and
efforts compared to immunoluorescence staining and con-
focal imaging that remain the gold standard to analyze
organoid fate in 3D cultures (25,26). Organoid structures
were classiied into four different categories according to
(27): round and regular polarized organoids with a hol-
low lumen resembling acinar structures of glandular tis-
sues (acini), round and regular full structures (round), dis-
organized and irregular full spheroid structures (spheroid),
loose, disorganized irregular full structures with invading
cells migrating outside the organoid (invasive spheroid)
(Figure 5A). This morphology-based classiication allows
the quantiication of the tumorigenic potential of different
cell lines and the quick visualization of different conditions.
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Western blot analysis
Cells were extracted from Matrigel microbeads by com-
bining prolonged trypsin incubation and several vortex
steps (Supplementary Figure S1). Cell recovery (Corning®
Cell Recovery Solution, 100 ml (Product #354253) was
further used to remove all traces of Matrigel. This solu-
tion enables the recovery of cells cultured on Corning®
Matrigel® Basement Membrane Matrix for subsequent
biochemical analyses. It has been tested for its ability to
depolymerize a 1 mm thick layer of gelled Matrigel Ma-
trix after 1 h at 2–8◦C. Briely, after trypsin digestion of
Matrigel microbeads, cells and remaining traces of Ma-
trigel were pelleted by centrifugation (5 min at 150 g), su-
pernatant was discarded and 1 ml of cell recovery was
added. Samples were mixed and incubated for 30 min at
4◦C. Cells were pelleted by centrifugation (5 min at 150 g)
and rinsed twice in PBS 1× before protein extraction for
western blot analysis. Cellular proteins were extracted us-
ing a RIPA lysis buffer (Sigma-Aldrich) that was comple-
mented with a protease inhibitor cocktail (Roche Diagnos-
tics, Cat. No. 11697498001, Sigma-Aldrich). According to
manufacturer’s instructions, one tablet was used extempo-
raneously to prepare 50 ml of protein extraction solution.
After quantiication with a Pierce BCA protein assay kit
(Thermo Fisher Scientiic), equal amounts of total protein
(typically 10 ng of protein per sample) were separated via
electrophoresis on a NuPAGE™ Novex™ 4–12% Bis-Tris
Protein Gel (Life Technologies) in MES buffer and then
transferred onto a nitrocellulose membrane (D. Dutscher,
Brumath, France). The membranes were blocked in 5%
non-fat milk in Tris-buffered saline, 0.1% Tween 20 (TBS-
T, Sigma) for 1 h at room temperature (RT) and incubated
with primary antibodies diluted at 1:1000 in 5% non-fat
milk in TBS-T overnight at 4◦C. Rabbit polyclonal antibod-
ies directed against p63 (Cell Signaling Technology, Ozyme,
St Quentin Fallavier, France), PTEN (Cell Signaling Tech-
nology) and GAPDH (Santa Cruz Biotechnology, Heidel-
berg, Germany) were used. Membranes were washed three
times for 10 min in TBS-T and incubated with secondary
horseradish peroxidase-conjugated antibodies (anti-rabbit,
eBiosciences, Paris, France) at a dilution of 1:10 000 in TBS-
T for 50 min. Membranes were washed three times for 10
min in TBS-T and developed using the Amersham ECL™
Prime Western Blotting System (D. Dutscher). Chemilumi-
nescence was analyzed using a ChemiDoc Touch Imaging
System (BioRad, Marne-la-Coquette, France), and quan-
tiication of the intensity of the bands was performed using
the ImageLab™ Touch Software (BioRad).
Immunoluorescence staining
Matrigel microbeads were immobilized at the bottom of
wells usingCelltak coating (7g/cm2 of surface area, Corn-
ing) followed by a quick centrifugation (30 s at 200 g). Then,
microbeads were ixed using 2% paraformaldehyde for 20
min and permeabilized with Trisbuffered saline (TBS) 0.5%
Triton X-100 (Sigma-Aldrich) for 10 min at RT. To prevent
non-speciic adsorption of antibodies, microbeads were in-
cubated with TBS-T 0.1% BSA 10% goat serum for 1 h
at RT. Primary antibodies (rabbit anti-giantin 1:400) were
added in TBS-T 0.1% BSA 10% goat serum overnight at
4◦C. Primary antibodies were washed away four times with
TBS-T for 15 min, and secondary antibodies (Rabbit-Cy3
1:400, Sigma-Aldrich) were added in TBS-T 0.1%BSA 10%
goat serum for 1 h at RT. F-actin was labeled with 500-
fold diluted FITC-phalloidin (Sigma-Aldrich), and nuclei
were counterstained with 1 g/ml Hoechst 33258 (Molecu-
lar Probes, Life Technologies) in TBS-T 0.1% BSA 5% goat
serum for 30 min. Finally, microbeads were washed twice
with TBS-T, and luorescence images were taken using an
AxioObserver.Z1 inverted microscope (Zeiss, Marly-le-Roi,
France) mounted with an AxioCam 503 monochrome digi-
tal camera or a confocal spinning-disk inverted microscope
(Nikon TI-E Eclipse) equipped with an Evolve EM-CCD
camera. Hoechst, FITC and Cyanine 3 (Cy3) luorophores
were excited and collected sequentially (400Hz line by line).
Controls for auto-luorescence or non-speciic signal were
performed by incubating microbeads without antibodies or
with luorochrome-matching isotype controls.
Statistical analysis
All data are represented as a mean of at least three separate
experiments. Statistical signiicance was determined using
theMann–Whitney-Wilcoxon test using R software. Signif-
icant P-values are indicated by an asterisk (*P < 0.05; **P
< 0.01; ***P < 0.0001).
RESULTS
Automatic generation of microencapsulated organoids
The process of microencapsulation was previously de-
scribed (20). Because the process of droplet formation is
highly repeatable under laminar low conditions, it is pos-
sible to produce thousands of identical bioreactors. As pre-
viously demonstrated, our approach enables and improves
acini culture homogeneity, recovery of 3D structures for
further analysis such as fundamental genomics, throughput
of the 3D culture preparation and most importantly high-
throughput analysis, as we have shown by applying large-
particle FACS. Now that feasibility has been demonstrated,
progress has been made in our group on process automa-
tion. To do so, plastic chips with low-focusing geometry
connected to a FlowPad microluidic platform were inte-
grated within a bench-top cooler system (Figure 1A) (‘Ma-
terials and Methods’ section). This setup allows the auto-
matic generation of homogeneous organoids that are em-
bedded within microbeads of controlled size, composition
and cell distribution (Figure 1B-a) (20). The table in Figure
1B recapitulates the beneits of this setup compared with
2D culture or standard 3D culture in Lab-Tek chambers. In
each microbead, one single cell will give rise to an organoid
derived from clonal origin. One single cell was encapsulated
initially and acinar/spheroid morphology was assessed on
∼400 cells for RWPE1 following 7 days of growth. For
breast acinar formation, following 14 days, the inal number
of cells was dificult to determine since it could, in theory,
reach several thousands of cells per acini. This setup would
be compatible with high-throughput screening applications
and is less expensive than traditional 3D culture because it
requires two to three times less Matrigel to obtain the same
amount of organoids. For example, 350 l of Matrigel for
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one well of a Lab-Tek 4-chambers slide allows to produce
42802microbeads with a diameter of 250m (Figure 1B-b).
Finally, these organoids are easy to handle, allowing us to
store them for long periods by using cryopreservation pro-
cedures.
Direct transfection of organoids in Matrigel microbeads
To evaluate the potential of micro-encapsulation for
siRNA transfections into 3D organoids, we compared
the transfection eficiency of the most common methods,
namely, liposome/polymer-mediated transfection (Lipofec-
tamin and Oligofectamin), electroporation (AMAXA sys-
tem) and virus-mediated delivery (Lentiviral vector). We
also evaluated compounds that are speciically designed
to improve 3D culture transfections (TransIT, 3DFect and
3DFectIn). We used green luorescent protein (GFP) to
evaluate the extinction eficiency in 3D cultures. To this
end, a prostate RWPE-1 cell line that stably expresses GFP
was engineered using lentiviral vectors. RWPE-1-GFP was
irst used as a fast growing and well-characterized cel-
lular model for normal epithelial acinar morphology in
3D cultures. Single RWPE-1-GFP cells were encapsulated
and allowed to develop into organoids for 4 days before
being transfected using siRNA directed against the GFP
gene or siRNA AllStars as a control. After 3 days of
culture, transfection eficiency was quantiied by analyz-
ing the GFP luorescence intensity in cells that were ex-
tracted from organoids via low cytometry (Figure 2A; Sup-
plementary Figures S3 and 4). Actually, we measured the
siRNA transfection eficiency because, at the same time, we
monitored the siRNA transfection and target gene (GFP)
knock-down. As expected, siRNA alone without any vec-
tors was not suficient to transfect organoids. Lipofectamin
and Oligofectamin demonstrated low extinction eficiencies
(≈5%), while TransIT, 3DFect and 3DFectIn reached up
to 15% extinction eficiency (Figure 2B). Then, we used
lentiviruses containing GFP shRNA expressing constructs
in the presence of polybrene with or without Puromycin se-
lection. The best results were obtained with an MOI (esti-
mated number of virus per cell) of 10, which led to a 25%
decrease in GFP luorescent signal (Supplementary Figure
S5). Finally, the highest results were obtained using electro-
poration, with GFP silencing eficiencies of almost 80% (P
= 0.029). To ensure that the reduction of luorescent signal
was due to GFP silencing and not to the transfection pro-
tocol, cell death was evaluated using trypan blue dye exclu-
sion staining and Caspase-3/7 detection. A small but not
signiicant (ns) decrease in cell viability (from 91 to 88%)
(P= 0.1) was observed in cells subjected to electroporation
or to lentiviral transduction (Figure 2C). In other experi-
ments, a not signiicant decrease in cell viability was also
observed (from 85 to 74%) (ns, P = 0.1) (Supplementary
Figure S6). These results highlight the eficiency and inocu-
ity of electroporation to transfect RWPE-1 organoids in mi-
crobeads comparedwith other techniques. The versatility of
thismethodwas also showed by successfully transfecting tu-
morigenic cell lines which form full tumor-like spheroids in
the beads (Supplementary Figure S7).
siRNA transfection can be achieved at the center of organoids
in microbeads
Even in spheroid models produced by cell aggregation and
devoid of ECM, direct 3D transfection is usually limited to
the outer layer of cells (28), which reduces its relevance and
leads to heterogeneous results. From this perspective, we de-
cided to assess siRNA penetration inside organoids using
electroporation of Alexa Fluor 546-labeled siRNA. RWPE-
1 organoids were allowed to develop for 4 days in Matrigel
microbeads before being transfected. After 3 days of cul-
ture, cell nuclei were stained with Hoechst, and luorescence
images were taken using a spinning disk confocal micro-
scope.We purposely display an organoid without hollow lu-
men (full of cells) to show the extent of siRNA penetration
in cells that are located at the center of 3D structures (Figure
3A). We observed a homogeneous distribution of siRNA in
organoids, even in the cells that are located at the center of
3D structures. We further used low cytometry analysis on
cells that were extracted from transfected organoids, which
demonstrated that almost 90% of RWPE-1 cells have inte-
grated the labeled siRNA (P = 0.05) (Supplementary Fig-
ure S8A). These results are consistent with the measured
transfection eficiency, as shown in Figure 2B. Given the
eficiency of this technique regarding siRNA transfection,
we wondered whether this can also be used for bigger nu-
cleic acids such as expression vectors.We then assessed plas-
mid penetration inside organoids using electroporation of
GFP-expressing plasmid. A dose-response curve was per-
formed with p-GFP (Supplementary Figure S9). RWPE-1
organoids were allowed to develop for 4 days in Matrigel
microbeads before being transfected. After 3 days of cul-
ture, cell nuclei were stained with Hoechst and luorescence
images were taken using a spinning disk confocal micro-
scope. We observed a homogeneous distribution of GFP-
expressing cells in organoids, even in cells that are located
at the center of 3D structures (Figure 3B). We further used
low cytometry analysis on cells that were extracted from
transfected organoids and demonstrated that more than
40% of RWPE-1 cells were expressing the GFP protein (P=
0.004) (Supplementary Figure S8B). Despite these promis-
ing results, a high heterogeneity was observed between ex-
periments when using plasmids. Indeed, most of the cells
were expressing GFP in some organoids while only a few
cells were expressing the GFP in others. This is probably
due to the size of the plasmid (∼5000 bp) when compared
to siRNA (20 bp), as previously described (6). This differen-
tial GFP expressionmay also be related to the fact that large
molecules such as plasmid DNA face physical barriers (nu-
clear envelope in addition to cytoplasmic membrane), be-
fore reaching the nucleus, while small molecules like siRNA
freely cross the electropermeabilized membrane and have a
free access to the cytoplasm. Moreover, this process may
be emphasized by a slower diffusion of plasmids through
the matrix and may contribute to reduce transfection efi-
ciency (29). However, these results clearly demonstrate the
general applicability of microbead electroporation to trans-
fect siRNA and to a lower extent plasmids, even into cells
that are located at the center of organoids.
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Figure 2. Direct transfection of organoids in Matrigel microbeads. (A) Experimental protocol for direct transfection of encapsulated RWPE-1-GFP
organoids. Encapsulated RWPE-1-GFP cells were allowed to develop into organoids for 4 days and were then transfected with siRNA (control siAllStars
and siGFP, 20 nM) for 3 days before analysis. (B) After 3 days of transfection by comparing different techniques, cells were extracted from microbeads
and analyzed via low cytometry. GFP knock-down was determined using the GFP MFI measurement as follows: GFP knock-down = 100 − (MFI
siGFP/MFI siAllStars)× 100. Results are expressed as the percentage of GFP signal extinction and represent the mean value± SEM of three experiments
(*P < 0.05). (C) Cell viability was measured via trypan blue dye exclusion staining.
Improving transfection eficiency by modulating microbead
size and Matrigel concentration
To validate the extensive applicability of 3D organoid elec-
troporation, we compared the extinction eficiency of 2D-
cultured cells and 3D-organoids that are derived from
prostate RWPE-1 and breast MFC10A cell lines. As pre-
viously observed, electroporation was found to be very ef-
fective for transfecting RWPE-1 cells. Interestingly, extinc-
tion eficiency was even higher in encapsulated organoids
compared with 2D-cultured cells (77 versus 65%) (ns, P =
0.114) (Figure 4A). In contrast, electroporation eficiency
was found to be lower in MCF10A cells compared with
RWPE-1 cells under 2D culture conditions (from 65 to 57%)
(ns, P = 0.5) and further decreased when performing direct
3D organoid transfection (from 57% in 2D to 31% in mi-
crobeads) (P = 0.024). Cell viability was found to be more
than 85% under all conditions (Figure 4B). A small but not
signiicant decrease (∼5%) in cell viability was observed af-
ter 3D transfection compared with 2D transfection in both
RWPE-1 and MCF10A cells. However, this is probably due
to the cell extraction process, which combines prolonged
trypsin incubation and several vortex steps (‘Materials and
Methods’ section) that are needed to extract cells fromMa-
trigel microbeads before assessing their viability. Because in
some cases ECM seems to be the major obstacle to siRNA
transfection in 3D organoids, we decided to modulate Ma-
trigel quantity around organoids to optimize transfection
eficiency, particularly for MCF10A organoids. To do so,
we adjusted two parameters: microbead size (cf diameter Ø)
andMatrigel concentration. InRWPE-1 cells, no signiicant
difference was observed when varying microbead size (from
450 to 250 m) orMatrigel concentration (from 70 to 50%)
(Figure 4C). This is probably because the extinction efi-
ciency was already high. In contrast, transfection eficiency
increased from 23 to 36% when decreasing microbead size
(from 450 to 250 m) and from 23 to 38% when decreas-
ing Matrigel concentration (from 100 to 70%) in MCF10A
organoids. Finally, we were able to reach up to 57% extinc-
tion eficiency when decreasing both microbead size and
Matrigel concentration in MCF10A organoids (P = 0.05).
This extinction eficiency is equal to the one we previously
observed in 2D-cultured MCF10A cells (Figure 4A). Alto-
gether, these results demonstrate the possibility of increas-
ing extinction eficiency in organoid refractory for electro-
poration by optimizing parameters such as microbead size
and Matrigel concentration to decrease Matrigel quantity
around 3D structures. By doing so, we obtained extinction
eficiencies that are comparable between 2D cultures and
3D organoids.
Discriminating differentiated organoids from tumor-like
spheroids based on morphological criteria
Current analysis of organoids uses confocal microscopy
and is thus limited by time-consuming acquisitions and the
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Figure 3. siRNA versus plasmid penetration into organoids that are grown in Matrigel microbeads. Fluorescent siRNA penetration (A) or GFP plasmid
expression (B) inside encapsulated RWPE-1 organoids was assessed using low cytometry and spinning disk confocal microscopy (40×magniication, scale
bar 100 m) 3 days after electroporation with 20 nM luorescent siRNA or GFP plasmid (*P < 0.05; **P < 0.01). False color imaging is used here for
better visualization.
need for human assistance, which hampers their applicabil-
ity for pharmaceutical studies. Here, we used morpholog-
ical classiication as a quick and reliable read-out to dis-
criminate organoid features and gene functions, as previ-
ously described (27). During glandular tumor development,
the cells irst begin to proliferate at the center of differenti-
ated acini leading to the formation of polarized but hyper-
plasic structures. Cell polarization will then progressively
be lost, which leads to the formation of disorganized and
irregular tumor-like spheroids. Finally, cells or groups of
cells will begin to migrate outside the tumor mass to in-
vade the surrounding tissues, which ultimately leads to the
formation ofmetastasis. Following this reasoning, organoid
structures were discriminated into four different categories:
round and regular polarized organoids with a hollow lu-
men that resembles acinar structures of glandular tissues
(acini), round and regular full structures (round), disorga-
nized and irregular full tumor-like structures (spheroid),
and loose, disorganized irregular full structures with cells
migrating outside the spheroid (invasive spheroid) (Figure
5A). We believe that this classiication relects the differ-
ent stages of tumor development and can thus be used to
quantify tumorigenic potential of the cells. To further vali-
date its relevance for distinguishing normal from tumor-like
phenotypes, we performed morphological classiication of
organoids, which were obtained from epithelial cells lines
(Supplementary Figure S10): ive prostate cell lines (RWPE-
1, PC3, DU145, LNCaP and WPE1-NB26) and two breast
cell lines (MCF10A and MCF7) that correspond to dif-
ferent stages of the disease (Figure 5B). As expected, we
observed an increased proportion of spheroids and inva-
sive spheroids in all tumor cell lines (PC3, DU145, LNCaP,
WPE1-NB26 and MCF7) compared with the control cell
lines (RWPE-1 and MCF10A) (30). MCF10A cells dis-
played a higher acini-forming capability compared with
RWPE-1 cells (respectively 80 and 50%) (P = 0.004). This
was accompanied by a lower percentage of round structures
(17 versus 34%) (P = 0.048) as well as spheroids (3 versus
13%) (P = 0.004) and invasive spheroids (0 versus 3%) (P
= 0.004). Interestingly, 5% of the PC3-derived organoids
were able to differentiate into hollow acini, while this phe-
nomenon was rarely observed for other cancer cell lines.
These results are consistent with a previous study, which
demonstrates that PC3 cells probably retain some differenti-
ation capabilities (31). Among the cancer cell lines we stud-
ied, PC3 and MCF7-derived organoids demonstrated the
highest invasive capabilities, as supported by high percent-
ages of invasive spheroids (respectively 9 and 11%). Alto-
gether, these results support the use of morphological crite-
ria to systematically discriminate glandular organoids from
tumor-like spheroids.
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Figure 4. Improving transfection eficiency by modulating microbead size and Matrigel concentration. RWPE-1-GFP and MCF10A-GFP-encapsulated
organoids or 2D cell cultures were electroporated with siRNA (control siAllStars and siGFP, 20 nM). After 3 days, transfection eficiency (A) was deter-
mined using low cytometry via GFPMFI measurement, as follows: transfection eficiency = 100− (MFI siGFP/MFI siAllStars)× 100 and cell viability
(B) was measured via trypan blue dye exclusion staining. The results represent the mean value ± SEM of three experiments (*P < 0.05). (C) Transfection
optimization in MCF10A organoids: MCF10A-GFP microbeads of different sizes (450 and 250 m in diameter Ø) and Matrigel concentrations (70 and
100%) were produced and electroporated with siRNA (control siAllStars and siGFP, 20 nM). After 3 days, extinction eficiency was determined using low
cytometry, as previously described. (D) Transfection optimization in RWPE1 organoids: RWPE-1-GFP microbeads of different sizes (450 and 250 m in
diameter Ø) and Matrigel concentrations (50 and 70%) were produced and electroporated with siRNA (control siAllStars and siGFP, 20 nM). After 3
days, extinction eficiency was determined using low cytometry, as previously described.
Gene silencing in Matrigel microbeads validates p63 and
PTEN as key genes in mammary and prostatic acinar devel-
opment
To further validate the versatility of direct organoid electro-
poration to identify tumor-suppressor genes during acinar
development, we inhibited p63 and PTEN expression, two
genes that are described as tumor-suppressors that play a
key role in breast and prostate tissue development (32–35).
To do so, prostate RWPE-1 and breast MCF10A organoids
were allowed to develop in microbeads for 4 and 10 days, re-
spectively, before performing transfection. Organoids were
then cultured for 3 days before being analyzed. Cells were
extracted from microbeads, and western blot analysis was
performed on total protein extracts after the complete Ma-
trigel removal (‘Materials and Methods’ section). We used
antibodies directed against p63, PTEN and GAPDH as
an internal control (Figure 6A). The results demonstrate
no difference between untreated controls and organoids
that are transfected with siRNA AllStars, while p63 and
PTEN protein levels were effectively decreased by ∼50% in
both RWPE-1 and MCF10A models. We then performed
morphological classiication of organoids as previously de-
scribed (Figure 5A). We observed no difference in the pro-
portion of different morphological categories between un-
treated organoids or organoids transfected with siRNAAll-
Stars (Figure 6B). This demonstrates that the transfection
method does not affect acini development in eitherRWPE-1
or MCF10A models. However, when transfecting RWPE-1
organoids with siRNAdirected against p63, we observed an
increase in both spheroids (from 14% to 31%) (P = 0.008)
and invasive spheroids (from 2% to 6%) (P = 0.056) at the
expense of acini (from 52 to 30%) (P = 0.008) compared
with transfection with siRNA AllStars. When performing
transfection with siRNA directed against the PTEN gene,
we also observed an increase in spheroids (from 14 to 27%)
(P = 0.008) and invasive spheroids (from 2 to 4%) (P =
0.095) at the expense of acini (from 52 to 36%) (P= 0.016).
Similar results were obtained using MCF10A organoids,
with an increase in round structures (from 19 to 33% for
p63 inhibition (P = 0.008) and 19 to 29% for PTEN inhi-
bition (P = 0.008)), spheroids (from 3 to 7% for p63 inhi-
bition (P = 0.008) and 3 to 6% for PTEN inhibition (P =
0.008)) and invasive spheroids (from 0.07 to 0.18% for p63
inhibition (P = 0.016) and 0.07 to 0.24% for PTEN inhibi-
tion (P = 0.016)). This was accompanied by a decrease in
the percentage of acini from 78 to 60% for p63 inhibition
(P = 0.008) and from 78 to 65% for PTEN inhibition (P =
0.008). This marks a failure of cell polarization and lumen
clearance, which leads to the generation of spheroids that
consist of loosely associated disordered cells in the absence
of either p63 or PTEN expression during organoid devel-
opment. Interestingly, we observed no signiicant difference
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Figure 5. Discriminating differentiated acini from tumor-like spheroids based on morphological criteria. (A) Encapsulated RWPE-1 cells were allowed
to develop into organoids for 7 days. Organoid structure was then discriminated into four different categories: round and regular polarized organoids
with a hollow lumen resembling acinar structures of glandular tissues (acini), round and regular full structures (round), disorganized and irregular full
spheroid structures (spheroid), and loose, disorganized irregular full structures with invading cells migrating outside the organoid (invasive spheroid). (B)
Morphological classiication of organoids, which were obtained from ive prostate cell lines (RWPE-1, PC3, DU145, LnCaP and WPE1-NB26) and two
breast cell lines (MCF10A and MCF7) that originated from benign or tumor tissues.
when comparing the size of organoids between the differ-
ent conditions in RWPE-1 and MCF10A models (Figure
6C), which shows the relevance of morphological classii-
cation used here. Finally, encapsulated organoids were im-
mobilized using Celltak coating and ixed before perform-
ing immunoluorescence staining for nucleus (Hoechst), F-
Actin (Phalloidin) and Golgi apparatus (anti-Giantin anti-
body) (Figure 6D). RWPE-1 and MCF10A cell lines gave
rise to polarized hollow acini in both controls (untreated
and siRNAAllStars), as shown by the absence of cells at the
center of acini and by the apical localization of the Golgi
apparatus. In contrast, organoids transfected with siRNA
that targeted p63 or PTEN failed to develop into fully dif-
ferentiated acini, which demonstrates a tumor-like pheno-
type, as evidenced by the loss of polarity and the presence
of cells at the center of 3D structures. Altogether, these re-
sults demonstrate that electroporation of organoids that are
grown in Matrigel microbeads is eficient in decreasing p63
and PTEN expression and leads to the failure of acini devel-
opment accompanied by the transition toward a tumor-like
phenotype.
DISCUSSION
Even though 3D cultures are widely used as relevant mod-
els to study physiological and pathological processes, di-
rect 3D transfection remains challenging and limits high-
throughput genetic screening studies in 3D cultures.Despite
the wide use of siRNA, large efforts are still being made to
develop more effective and safe methods to deliver siRNAs
into cells, particularly in 3D cultures, and because of the
great clinical potential of RNAi to treat diseases.
To date, current 3D culture systems rely on multiwell
plates where cells that are embedded in ECM scaffolds
develop into heterogeneous and overlapping organoids,
limiting experiment reproducibility, analysis and gene de-
livery. Thus, there is a need for new culture formats to
produce homogeneous and easy-to-handle organoids for
high-throughput applications. Building on our previous mi-
croluidic chip which delivers highly controlled conditions
for the seeding and growth of polarized cellular acini within
Matrigel microbeads (20), we designed an automatic and
robust microluidic platform that provides incremental im-
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Figure 6. Gene silencing in Matrigel microbeads validates p63 and PTEN as common tumor suppressors during mammary and prostatic acinar devel-
opment. Encapsulated RWPE-1 or MCF10A cells were allowed to develop into organoids for respectively 4 and 11 days and were then transfected with
indicated siRNA at 20 nM for 3 days before western blot analysis (A), morphological discrimination (B), size measurement (C) or immunostaining (D)
for F-actin (Phalloidin-FITC, green), Golgi (Anti-Giantin Cy3, red) and nuclei (Hoechst, blue). Images were acquired using a spinning disk confocal
microscope (20 × magniication, scale bar 50 m).
provements toward a high-throughput production of well-
controlled organoids that are embedded within microbeads
(∼2000 microbeads/min).
In contrast to static 3D cultures in Lab-Tek chambers,
organoids that are grown in Matrigel microbeads are easy
to handle and can be manipulated at will to perform elec-
troporation. In addition, the reduced amount of Matrigel
surrounding organoids constitutes a permissive 3D envi-
ronment that facilitates transfection. Taking advantage of
these characteristics, we demonstrate that direct electropo-
ration of encapsulated organoids reach up to 80% trans-
fection eficiency in RWPE-1 organoids. Despite reaching
lower transfection eficiencies in MCF10A organoids, we
also showed that gene silencing can be improved by tuning
parameters such as microbead size or Matrigel concentra-
tion. In contrast with a previous study demonstrating low
plasmid transfection eficiency (about 6%) in 3D cultures
(30), we managed to reach plasmid extinction eficiency of
more than 40%. Moreover, in a recent study (36) demon-
strating the beneits of a novel gas plasma-facilitated cel-
lular transfection method, siRNA extinction eficiency of
about 20% (as compared to more than 80% in our system)
and plasmid transfection eficiency of less than 5% (as com-
pared to more than 40% in our system) were reached in
a 3D culture system. Strikingly, we managed for the irst
time to reach siRNA transfection eficiencies that are com-
parable between 2D cultures and 3D organoids. While viral
transduction systems usually allow higher transfection efi-
ciencies, it has been demonstrated that ECM impedes virus-
mediated gene delivery since its digestion dramatically im-
proves extinction eficiency (12), which explains the limited
effect on Matrigel microbeads. Direct organoid electropo-
ration is particularly useful for transfecting long-term cul-
tured organoids and at different development stages. For
example, the siRNA effect would be totally lost if perform-
ing 2D transfection before 3D culture using MCF10A cells
because they need a minimum of 14 days to fully develop
into differentiated acini. Thus far, different methods have
also been successfully developed to achieve eficient trans-
gene expression in 3Dmodels. For example, retroviral infec-
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tion allowed the sustained expression of GFP in more than
90% of cells from organoid fragments that were removed
from Matrigel (12). In other studies, researchers managed
to achieve high transfection eficiencies using polyplex na-
nomicelles (37), lexible nanocarriers (38) or polyamine
nanoparticles (39) on MCTS. However, these studies were
performed on incomplete 3Dmodels, cell aggregates such as
MCTS or dissociated organoids devoid of any exogenous
ECM (40). A viable strategy to transfect ECM-embedded
organoids is to use inducible systems (41). Nonetheless,
while ensuring a controlled and eficient transfection, this
system is hardly compatible with high-throughput analysis.
In another study, MCTS from mouse sarcoma were trans-
fected via electroporation in the presence of propidium io-
dide. The method was highly eficient since practically the
entire cell population was permeabilized, as measured by
propidium iodide uptake (28). In addition, no difference
was detected between cells at the periphery and the cells lo-
cated deeper within the spheroid’s core. However, the up-
take eficiency of macromolecules such as plasmid DNA
was found to be ineficient. Indeed, only a few cells from
colon cancer MCTS were transfected using a plasmid that
codes for theGFP. A striking observation is that transfected
cells were heterogeneously distributed and appeared to be
only localized in the outer layers of the spheroids. These re-
sults suggest that limited access to central regions ofMCTS
remains a signiicant barrier to gene delivery. Indeed, close
contacts between cells may act as physical barriers that limit
the diffusion of plasmid DNA and therefore its access to
cells present in the core of the spheroid. In contrast, our
results demonstrate high levels of siRNA molecule pene-
tration through ECM and increased eficacy in quiescent
cells at the center of organoids afforded by electroporation,
which makes it a promising strategy for gene silencing stud-
ies. Thus, the combination of organoid microencapsulation
and eficient siRNA delivery methods developed here en-
compasses existing techniques, and allows the transfection
of physiological organoid cultures embedded in ECM that
mimic complex tissue development steps.
Using this system, we further explored the effects of p63
and PTEN gene silencing on acini formation. To do so, we
used morphological classiication as a read-out to distin-
guish healthy organoids from tumor spheroids. We believe
that this classiication contains better criteria compared
with 3D structure size to discriminate healthy organoids
from tumor spheroids. In this study, morphological anal-
ysis of 3D structures was performed by eye counting un-
der a phase microscope, which remains time consuming and
laborious, although more rapid that the conventional im-
munostaining and confocal z-stack analysis. However, an
automatic image analysis software is currently under devel-
opment and will be applied to discriminate the different cat-
egories of organoids to meet the need of high-throughput
screening applications. Indeed, we observed no signiicant
difference between the sizes of organoids after p63 or PTEN
inhibition, while we observed a signiicant increase in the
proportion of spheroids at the expense of fully differentiated
acini. This difference could be explained by an increase in
cell proliferation and/or a loss of apoptosis, which occurs
at the center of acini, leading to an increase in cell num-
ber progressively illing the lumen. This phenomenonwould
likely not be relected at irst by an increase in the overall
size of organoids because of cell proliferation that occurs at
the center of 3D structures such as for in situ carcinoma.
We observed that down-regulation of p63 and PTEN led to
the failure of acinar development as evidenced by the lack
of cell polarization, lumen clearance and the generation of
spheroids that consist of loosely associated disordered cells.
These results validate the roles of p63 and PTEN as tumor-
suppressor genes that play a key role in acinar development
in both breast and prostate tissues.
Our results highlight the potential of microencapsu-
lated organoid electroporation to study tissue development
and tumorigenesis and provide valuable tools that should
ind versatile applications in fundamental research and
organoid/spheroid-based drug assays. Being able to per-
form organoids versus tumor-like spheroids discrimination
using label-free and real time low-based strategies would
prove very convenient for the future High Content Screen-
ing in 3D models. We believe that in addition to high-
throughput screening for functional genomics studies, this
approach will also be useful in identifying potential RNAi
therapeutics and in probing their effectiveness in a 3D cul-
ture environment that will more accurately predict in vivo
cell response.
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